Dr. Alexander Satz, PhD
Executive Director of DEL Platform, Crelux Managing Director DEL, OBOC, D2B, MedChem, Other Screening Methods, Molecular Glue Degrader, PROTAC, Peptides
Dr. Alex Satz is the Executive Director of DEL Platform and Crelux Managing Director with over 17 years of experience building and leading DNA-encoded library (DEL) technology platforms. Before joining WuXi AppTec, Dr. Satz built and led the Roche DEL platform in Basel, Switzerland, and Nutley, USA, and helped develop the first industrial-scale DEL platform at Praecis Pharmaceuticals (later purchased by GlaxoSmithKline). Dr. Satz trained as a medicinal chemist at AstraZeneca, completed an NIH postdoctoral fellowship at Harvard Medical School, and earned his PhD in Organic Chemistry from the University of California, Santa Barbara. He has authored 18 peer-reviewed articles and two book chapters in the field of DEL.